Dana-Farber Cancer Institute, Inc.
Dana-Farber Cancer Institute, Inc., headquartered in the United States, is a leading institution in cancer research and treatment. Founded in 1947, it has established itself as a pioneer in the oncology field, focusing on innovative therapies and comprehensive patient care. With major operational regions across New England, Dana-Farber is renowned for its commitment to advancing cancer research and providing cutting-edge treatments.
The institute offers a range of services, including clinical care, research, and education, with a unique emphasis on personalised medicine. Its multidisciplinary approach integrates the latest scientific discoveries with compassionate patient support, setting it apart in the competitive healthcare landscape. Dana-Farber's notable achievements include significant contributions to cancer research and a strong reputation for excellence, making it a trusted name in the fight against cancer.
-17 vs industry average
Dana-Farber Cancer Institute, Inc.’s score of 13 is lower than 31% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Dana-Farber Cancer Institute, Inc.?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Research Services has typical carbon intensity
Industry performance
The Research Services industry has reduced its overall emissions by 19% since 2018
Reported emissions
No reported emissions data is available for Dana-Farber Cancer Institute, Inc. yet.
Dana-Farber Cancer Institute, Inc.'s reported carbon emissions
Dana-Farber Cancer Institute, Inc., headquartered in the US, currently does not have available carbon emissions data for the most recent year. As such, there are no specific figures regarding their total emissions or breakdowns by Scope 1, 2, or 3.
Additionally, there are no documented reduction targets or climate commitments, including those from the Science Based Targets initiative (SBTi) or other climate pledges. This absence of data suggests that Dana-Farber may still be in the early stages of formalising its climate strategy or reporting on its emissions.
In the context of the healthcare sector, many organisations are increasingly prioritising sustainability and carbon reduction initiatives. However, without specific commitments or emissions data, it is unclear how Dana-Farber aligns with these industry trends.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Dana-Farber Cancer Institute, Inc.’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for Dana-Farber Cancer Institute, Inc. yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Emissions comparison with industry peers
View similar organisations
Dana-Farber Cancer Institute, Inc.
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project